Mangoceuticals (MGRX) Total Liabilities (2022 - 2026)

Mangoceuticals (MGRX) has 5 years of Total Liabilities data on file, last reported at $974571.0 in Q1 2026.

• For the quarter ending Q1 2026, Total Liabilities fell 35.17% year-over-year to $974571.0; the trailing twelve-month figure through Mar 2026 stood at $974571.0 (down 35.17% YoY), and the FY2025 full-year result was $890568.0, down 37.52% from the prior year.
• Total Liabilities improved to $974571.0 in Q1 2026, from $890568.0 in the prior quarter.
• In the past five years, Total Liabilities ranged from a high of $1.6 million in Q2 2025 to a low of $240684.0 in Q3 2023.
• A 5-year average of $911916.1 and a median of $932569.5 in 2025 frame the typical range for Total Liabilities.
• Across the five-year window, Total Liabilities soared 483.15% in 2024 and plunged 42.7% in 2025, its largest moves.
• Tracing MGRX's Total Liabilities over 5 years: stood at $389257.0 in 2022, then dropped by 29.09% to $276039.0 in 2023, then soared by 416.4% to $1.4 million in 2024, then plunged by 37.52% to $890568.0 in 2025, then increased by 9.43% to $974571.0 in 2026.
• Business Quant data shows MGRX's Total Liabilities at $974571.0 in Q1 2026, $890568.0 in Q4 2025, and $804275.0 in Q3 2025.